Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001445305-13-000615
Filing Date
2013-03-14
Accepted
2013-03-14 16:31:12
Documents
4
Period of Report
2013-04-16
Effectiveness Date
2013-03-14

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2013proxystatement.htm DEF 14A 619392
2 cumberlandlogoa02.jpg GRAPHIC 12534
3 untitleda01.jpg GRAPHIC 9167
4 x.jpg GRAPHIC 2405
  Complete submission text file 0001445305-13-000615.txt   653977
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: DEF 14A | Act: 34 | File No.: 001-33637 | Film No.: 13690847
SIC: 2834 Pharmaceutical Preparations